loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Selumetinib

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Selumetinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 17,197Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    China NMPA approves Koselugo for paediatric patients
    China NMPA approves Koselugo for paediatric patients

    08 May 2023

    // PHARMABIZ

    http://pharmabiz.com/NewsDetails.aspx?aid=158008&sid=2

    PHARMABIZ
    08 May 2023
    Share Share
    Koselugo approved in Japan for paediatric patients with plexiform neurofibromas
    Koselugo approved in Japan for paediatric patients with plexiform neurofibromas

    28 Sep 2022

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=153495&sid=2

    PHARMABIZ
    28 Sep 2022
    Share Share
    AstraZeneca Pharma India gets nod to import, market Selumetinib capsules
    AstraZeneca Pharma India gets nod to import, market Selumetinib capsules

    26 Sep 2021

    // BUSINESS-STANDARD

    https://www.business-standard.com/article/companies/astrazeneca-pharma-india-gets-nod-to-import-market-selumetinib-capsules-121092600914_1.html

    BUSINESS-STANDARD
    26 Sep 2021
    Share Share
    AstraZeneca Pharma India gets nod to import, market Selumetinib capsules
    AstraZeneca Pharma India gets nod to import, market Selumetinib capsules

    25 Sep 2021

    // BUSINESS-STANDARD

    https://www.business-standard.com/article/companies/astrazeneca-pharma-india-gets-nod-to-import-market-selumetinib-capsules-121092600914_1.html

    BUSINESS-STANDARD
    25 Sep 2021
    Share Share
    Selumetinib recommended for approval in the EU by CHMP as the first medicine
    Selumetinib recommended for approval in the EU by CHMP as the first medicine

    26 Apr 2021

    // PRESS RELEASE

    https://www.astrazeneca.com/media-centre/press-releases/2021/selumetinib-recommended-for-eu-approval-in-nf1.html

    PRESS RELEASE
    26 Apr 2021
    Share Share
    Selumetinib granted orphan drug designation in Japan neurofibromatosis type 1
    Selumetinib granted orphan drug designation in Japan neurofibromatosis type 1

    30 Jun 2020

    // PRESS RELEASE

    https://www.astrazeneca.com/media-centre/press-releases/2020/selumetinib-granted-orphan-drug-designation-in-japan-for-neurofibromatosis-type-1.html

    PRESS RELEASE
    30 Jun 2020
    Share Share